EP 0261891 A3 19900905 - PHARMACEUTICAL COMPOSITIONS CONTAINING ETIOCHIOLANDIONE
Title (en)
PHARMACEUTICAL COMPOSITIONS CONTAINING ETIOCHIOLANDIONE
Publication
Application
Priority
US 91041686 A 19860922
Abstract (en)
[origin: EP0261891A2] Etiocholandione is administered to mammals for the treatment of prophylaxis of diabetes, obesity, hpbercorticoidism and bone marrow suppressive disorders. Following administration the dione is converted to alphaetiocholanolone which is pharmaceutically active. The use of etiocholandione as a pharmaceutical and compositions containing it are described.
IPC 1-7
IPC 8 full level
A61K 31/565 (2006.01)
CPC (source: EP)
A61K 31/565 (2013.01)
Citation (search report)
- EP 0149220 A2 19850724 - JACKSON LAB [US], et al
- US 4507289 A 19850326 - COLEMAN DOUGLAS L [US], et al
- US 4602008 A 19860722 - KRSEK GEORGE [US]
Designated contracting state (EPC)
AT BE CH DE ES FR GB GR IT LI LU NL SE
DOCDB simple family (publication)
DOCDB simple family (application)
EP 87308287 A 19870918